Trials / Completed
CompletedNCT01090713
Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder
Lisdexamfetamine in Binge Eating Disorder of Moderate or Greater Severity
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Lindner Center of HOPE · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The specific aim of this study is to examine the efficacy and safety of lisdexamfetamine compared with placebo in outpatients with binge eating disorder
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lisdexamfetamine | oral; 20-70mg/day |
| DRUG | Placebo control | 20-70mg; oral |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2010-03-22
- Last updated
- 2016-07-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01090713. Inclusion in this directory is not an endorsement.